safeti stabil effect immunoadsorpt membran plasmapheresi treatment myasthenia gravi nine patient women men averag age year refractori myasthenia gravi MG underw thymectomi immunoadsorpt membran plasmaphersi iap thymic histolog hyperplasia patient immunoadsorpt column asahi med Co tryptophan plasouto asahi med Co machin plasma separ first filter asahi med Co immunoadsorpt column plasma perfus iap treatment time total time iap week remov rate anti-ach-r titer igg iga igm level patient iap treatment improv gait disturb muscl strength patient wherea disturb eye ptosi patient subject improv patient none sever side effect iap conclus iap safe stabl effect use treatment MG 